#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Scott Thacher Email
CEO and founder . Orphagen Pharmaceuticals
San Diego, CA
LocationPrimary Email
How to contact Scott Thacher
Join and see Scott's contact info for free!Phone
Current Roles
Employees:
7Revenue:
$1.1MAbout
Orphagen discovers and develops small molecules to drug targets that have significant unrealized potential in areas of high clinical need. We focus on the unexplored or “orphan†members of the nuclear receptor family. Nuclear receptors have been a rich source of successful drugs. Orphagen has identified drug-like small molecules to several orphan nuclear receptors and has described efficacy in animal models of disease. An early success led to a partnership with Japan Tobacco (JT) Pharma to discover and develop oral drugs to treat psoriasis and other autoimmune diseases. This partnership was the first in the industry for the nuclear receptor ROR-gamma. JTE-451, a product of the JT Pharma partnership, entered Phase 2 trials this year (in 2019). Orphagen has two major internal programs. One is to develop antagonists to the orphan nuclear receptor steroidogenic factor-1 (SF-1) for adrenocortical cancer (ACC) and other endocrine conditions. The second focuses on inflammatory disease. Orphagen also provides assay and screening services for the nuclear receptor family.Orphagen Pharmaceuticals Address
11558 Sorrento Valley RoadSan Diego, CA